Table 1.
Study Medications and Recommended Tests. Persons Prescribed the Following High-Risk Medications (or Classes) During 2008 Were Included in the Analysis
| Drug | Test | BBW** |
|---|---|---|
| ACE/ARB* | BMP† | |
| ALLOPURINOL | CREATININE | |
| AMIODARONE | AST‡ or ALT§ | X |
| TSH‖ | ||
| AZATHIOPRINE | AST or ALT | |
| CBC | X | |
| AZOLE ANTIFUNGAL | AST or ALT | X |
| CARBAMAZEPINE | AST or ALT | |
| CARBAMAZEPINE | ||
| CBC | X | |
| COLCHICINE | CBC | |
| CREATININE | ||
| CYCLOSPORINE | AST or ALT | |
| CREATININE | X | |
| CYCLOSPORINE | X | |
| DIGOXIN | CREATININE | |
| DIGOXIN | ||
| POTASSIUM | ||
| DIURETIC-LOOP | BMP or K¶+Cr | X |
| DIURETIC-NOT-K-SPARING | BMP or K+Cr | |
| DIURETIC-POTASSIUM SPARING | BMP or K+Cr | X |
| DIURETIC-THIAZIDE | BMP or K+Cr | |
| FENOFIBRATE | AST or ALT | |
| CBC | ||
| GEMFIBROZIL | AST or ALT | |
| ISONIAZID | AST or ALT | X |
| LITHIUM | CBC | |
| CREATININE | ||
| LITHIUM | X | |
| TSH | ||
| METFORMIN | CREATININE | X |
| METHOTREXATE | AST or ALT | X |
| CBC | X | |
| CREATININE | X | |
| METHYLDOPA | AST or ALT | |
| CBC | ||
| NEFAZODONE | AST or ALT | X |
| NIACIN | AST or ALT | |
| PHENOBARBITAL | AST or ALT | |
| CBC | ||
| PHENOBARBITAL | ||
| PHENYTOIN | AST or ALT | |
| PHENYTOIN | ||
| POTASSIUM | POTASSIUM | |
| PRIMIDONE | CBC | |
| PHENOBARBITAL | ||
| PRIMIDONE | ||
| QUINIDINE | AST or ALT | |
| CREATININE | ||
| POTASSIUM | ||
| QUINIDINE | ||
| RIFAMPIN | AST or ALT | |
| STATIN | AST or ALT | |
| TERBINAFINE | AST or ALT | |
| THEOPHYLLINE | THEOPHYLLINE | |
| THIAZOLIDINEDIONE | AST or ALT | |
| THYROID REPLACEMENT | TSH | |
| VALPROATE SODIUM | AST or ALT | |
| CBC | ||
| VALPROIC ACID | X |
*ACE/ARB, Angiotensin-Converting Enzyme Inhibitors/Angiotensin II Receptor Blockers; †BMP, basic metabolic panel; ‡AST, aspartate aminotransferase; §ALT, alanine aminotransferase; ‖TSH, thyroid stimulating hormone; ¶K, potassium; #Cr, creatinine; **BBW, Black Box Warning